Advisor Group’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$3K Buy
+41
New +$3.02K ﹤0.01% 4888
2018
Q3
Sell
-70
Closed -$8K 5229
2018
Q2
$8K Hold
70
﹤0.01% 4193
2018
Q1
$6K Sell
70
-27
-28% -$2.09K ﹤0.01% 4348
2017
Q4
$7K Buy
+97
New +$6.49K ﹤0.01% 4290
2017
Q2
Sell
-1,302
Closed -$75K 4915
2017
Q1
$75K Buy
1,302
+800
+159% +$47.8K ﹤0.01% 2385
2016
Q4
$31K Sell
502
-108
-18% -$7.04K ﹤0.01% 2947
2016
Q3
$43K Buy
610
+54
+10% +$3.56K ﹤0.01% 2650
2016
Q2
$30K Buy
+556
New +$33.5K ﹤0.01% 2792

Other funds holding USNA

Advisor Group's USNA Position: Q4 2019 in Review

Advisor Group opened a new position in Usana Health Sciences (USNA) in Q4 2019: 41 shares worth $3K. The stake represents ﹤0.01% of the portfolio and ranks #4888 among its holdings. This is a return to the name: Advisor Group previously reported a position in USNA as recently as Q2 2018.

Advisor Group first reported a position in USNA in Q2 2016 and has held it in 8 quarters since. The position peaked at $75K in Q1 2017. 175 funds tracked by Wall St. Rank hold USNA as of Q4 2019.

  • Advisor Group held 41 shares of Usana Health Sciences worth $3K as of Q4 2019.
  • Usana Health Sciences was a new Advisor Group position in Q4 2019.
  • Usana Health Sciences made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #4888 holding.
  • Advisor Group first reported a position in Usana Health Sciences in Q2 2016 and has held it in 8 quarters since.
  • Advisor Group's Usana Health Sciences position peaked at $75K in Q1 2017.
  • 175 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.